NasdaqCM - Nasdaq Real Time Price USD
Oncternal Therapeutics, Inc. (ONCT)
0.5266
-0.1674
(-24.12%)
At close: December 2 at 4:00:00 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 273.21k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| WILLS ROBERT JAMES Director | Purchase at price 8.96 per share. | Direct | 27,655 | Apr 8, 2024 |
| WILLS ROBERT JAMES Director | Purchase at price 8.48 per share. | Direct | 58,602 | Mar 28, 2024 |
| WILLS ROBERT JAMES Director | Sale at price 9.04 per share. | Direct | 8,859 | Feb 23, 2024 |
| HALE DAVID F Director | Purchase at price 9.04 per share. | Indirect | 8,859 | Feb 23, 2024 |
| KAUFMANN GUNNAR F Officer | Purchase at price 0.35 - 0.36 per share. | Direct | 9,824 | Jun 14, 2023 |
| BREITMEYER JAMES B Chief Executive Officer | Purchase at price 0.29 - 0.30 per share. | Indirect | 43,930 | Apr 14, 2023 |
| YAZJI SALIM M.D. Officer | Purchase at price 0.28 - 0.30 per share. | Direct | 7,200 | Apr 14, 2023 |
| VINCENT RICHARD G. Chief Financial Officer | Purchase at price 0.30 per share. | Direct | 8,961 | Apr 13, 2023 |
| LEAVITT CHASE C. General Counsel | Purchase at price 0.29 per share. | Direct | 7,250 | Apr 13, 2023 |
Related Tickers
27F0.F KALA BIO, Inc.
2.6940
+3.14%
AFMD Affimed N.V.
0.7703
+4.24%
OKUR OnKure Therapeutics, Inc.
2.7600
+6.15%
IKNA Ikena Oncology, Inc.
1.2100
+1.68%
GANX Gain Therapeutics, Inc.
1.8500
0.00%
STTK Shattuck Labs, Inc.
0.8513
-4.68%
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
ADCT ADC Therapeutics SA
1.2900
+4.88%
IPHA Innate Pharma S.A.
1.9955
+5.03%
TRDA Entrada Therapeutics, Inc.
8.71
0.00%